Navellier & Associates Inc. Buys Shares of 6,310 Masimo Corporation $MASI

Navellier & Associates Inc. purchased a new stake in Masimo Corporation (NASDAQ:MASIFree Report) in the 3rd quarter, HoldingsChannel.com reports. The firm purchased 6,310 shares of the medical equipment provider’s stock, valued at approximately $931,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Massachusetts Financial Services Co. MA increased its holdings in Masimo by 6.1% during the third quarter. Massachusetts Financial Services Co. MA now owns 2,619,960 shares of the medical equipment provider’s stock valued at $386,575,000 after buying an additional 149,567 shares during the period. State Street Corp boosted its position in Masimo by 0.7% during the 2nd quarter. State Street Corp now owns 1,486,394 shares of the medical equipment provider’s stock valued at $250,041,000 after acquiring an additional 10,403 shares in the last quarter. Westfield Capital Management Co. LP increased its holdings in shares of Masimo by 75.9% in the 2nd quarter. Westfield Capital Management Co. LP now owns 1,181,203 shares of the medical equipment provider’s stock valued at $198,702,000 after acquiring an additional 509,724 shares during the period. Durable Capital Partners LP raised its position in shares of Masimo by 3.4% in the 2nd quarter. Durable Capital Partners LP now owns 1,163,898 shares of the medical equipment provider’s stock worth $195,791,000 after acquiring an additional 38,279 shares in the last quarter. Finally, Geode Capital Management LLC lifted its stake in shares of Masimo by 6.2% during the 2nd quarter. Geode Capital Management LLC now owns 896,418 shares of the medical equipment provider’s stock worth $150,817,000 after purchasing an additional 52,100 shares during the last quarter. 85.96% of the stock is currently owned by institutional investors.

Masimo Stock Performance

MASI opened at $134.10 on Wednesday. The company has a market cap of $7.20 billion, a P/E ratio of -12.72, a price-to-earnings-growth ratio of 1.37 and a beta of 1.26. The company has a quick ratio of 1.92, a current ratio of 2.84 and a debt-to-equity ratio of 0.69. The firm’s 50-day moving average price is $136.97 and its 200-day moving average price is $143.18. Masimo Corporation has a 52-week low of $125.94 and a 52-week high of $194.88.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on MASI shares. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Masimo in a research report on Thursday, January 22nd. Zacks Research downgraded shares of Masimo from a “strong-buy” rating to a “hold” rating in a research report on Friday, October 24th. Wall Street Zen upgraded shares of Masimo from a “hold” rating to a “buy” rating in a research note on Tuesday, October 14th. Wells Fargo & Company reissued an “overweight” rating and set a $190.00 target price on shares of Masimo in a research report on Friday, December 5th. Finally, BTIG Research lifted their price target on shares of Masimo from $198.00 to $200.00 and gave the stock a “buy” rating in a report on Thursday, December 4th. Four investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Masimo currently has a consensus rating of “Hold” and a consensus price target of $189.40.

Check Out Our Latest Stock Analysis on MASI

About Masimo

(Free Report)

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.

Featured Stories

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASIFree Report).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.